US Patent Issued to Lay Sciences on March 24 for "Targeted anti-SGLT1 avian IgY antibodies as treatment of pre-diabetes, type 2 diabetes and gestational diabetes" (Indian Inventor)

ALEXANDRIA, Va., March 24 -- United States Patent no. 12,583,921, issued on March 24, was assigned to Lay Sciences Inc. (Jupiter, Fla.).

"Targeted anti-SGLT1 avian IgY antibodies as treatment of pre-diabetes, type 2 diabetes and gestational diabetes" was invented by Uday Saxena (Hydcrabad, India).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are methods for treating a disorder characterized by elevated blood glucose levels in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a hyperimmunized egg product obtained from an egg-producing animal, wherein the hyperimmunized egg product comprises a therapeutically effective amount of one or more IgY an...